IL6 and endothelial dysfunction: The last but not the least, studies show that pro-inflammatory molecules such as interleukin-1, interleukin-6, and tumor necrosis factor-α both stimulate osteoclast activity, which could raise β-CTX levels, and promote atherosclerosis by triggering endothelial dysfunction and plaque inflammation (25, 26).